England has begun to deploy that cancer treatment that is groundbreaking and capable of making a huge difference in the lives of thousands of patients. The injection-based therapy has been successfully employed in directing and treating 15 various cancers, which not only provides fresh expectations for the previously untreatable but also for those who have been waiting for a reliable way out of an almost hopeless situation.
A Very Promising Cure for Cancer
Atezolizumab, also known as the brand-name Tecentriq, is a high-tech and very impactful immunotherapy that contributes to the triggering of the immune system to recognize and destroy the cancer cells. This kind of therapy, quite the opposite of the traditional and somewhat rough chemotherapy that can hurt the good cells, which are killed by the way, targets the cancerous growths and none other, reducing the side effects and lessening the chance of dying.
As per The National Health Service (NHS), the shots will be available to the patients who are eligible and suffering from the following types of cancer such as:
- Lung cancer
- Breast cancer
- Bladder cancer
- Liver cancer
- Melanoma (skin cancer)
- Colorectal cancer
- A-ma-zing! And 10 other types of cancers
How Does It Work?
The main function of this drug is to stop the PD-L1 protein from functioning, which cancer cells use to remain invisible to the immune system. The drug treatment enables the body’s immune system to more efficiently recognize and destroy cancer cells by silencing this protein.
From clinical research, it is quite clear that the immunotherapy treatment was showing a positive change among patients who were faced with the following situations:
- Higher survival rates compared to conventional treatments
- Less severe side effects than chemotherapy
- The best quality of life during treatment
Widespread Availability and the Right Patients
This treatment has gotten the green light by The National Health Service for a designated set of patients, which mostly includes patients who had cancers that are advanced or metastatic, and have not had success from other forms of treatment. Practitioners will make case-by-case decisions about the eligibility of patients.
National health professionals working in England have greatly praised the tool that has opened up new possibilities in cancer treatment, and have reiterated the fact that it could result in cancer not being a fatal illness but a manageable one.
Cancer Therapy in the Days to Come
Will that make immune therapy replace traditional medicine? Not really. It is just part of the move to personalized medicine, which eliminates the one-size-fits-all approach and focuses on the genetic makeup and biological traits of every patient. Apart from that, scientists believe that the new method, either alone or in combination with the traditional one, will not only have the same healing effect but also offer less toxic options.
Before the story unfolds globally, England has taken up the challenge to implement this state-of-the-art treatment, and other countries are on their way to providing this novel therapy, which symbolizes hope not only to cancer patients in the UK but in the rest of the world as well.
